Grey Matter Does Not Continue to Thicken Throughout Adulthood

Scientific Knowledge on the Subject

Older individuals with obstructive sleep apnea are at risk of presenting with cognitive decline and dementia. Although previous studies investigated cerebral gray matter structure in obstructive sleep apnea, inconsistencies exist regarding the presence of changes and their specific locations in the brain. Furthermore, there is a lack of understanding regarding gray matter integrity in the aging population with obstructive sleep apnea, because few studies have specifically evaluated this age group.

What This Study Adds to the Field

This study assessed the relationship between intrinsic markers of obstructive sleep apnea severity and multiple measures of cerebral gray matter structure in a large sample of middle-aged and older individuals. We found that the main markers of obstructive sleep apnea severity are related to increased thickness and/or volume of the frontal, parietal, and cingulate regions of the cortex as well as the amygdala. These results suggest that obstructive sleep apnea in the aging and mostly presymptomatic population is associated with underlying cerebral adaptive/reactive mechanisms.

Repetitive airway collapses in obstructive sleep apnea (OSA) lead to chronic cycles of hypoxemia/reoxygenation and hypercapnia, hemodynamic fluctuations, and sleep fragmentation (1). According to animal models, these pathophysiological processes have consequences on the brain by provoking oxidative stress, cellular death, and cellular morphological modifications (2–4). Consequently, OSA may lead to structural cerebral gray matter changes. Considering that OSA is particularly common in the aging population (1) and is a risk factor for accelerated cognitive decline (5) and dementia (6), the relation between gray matter integrity and OSA severity in the older population must be assessed to deepen our understanding of its contribution to neurodegeneration.

In OSA, gray matter volume has been investigated predominantly in middle-aged adults, using voxel-based morphometry (VBM). A meta-analysis showed that OSA correlates with a smaller parahippocampal and frontotemporal cortex (7). However, because of variations between studies (e.g., VBM pipeline, apnea–hypopnea index [AHI] thresholds), others argue that there is currently no clear evidence of gray matter atrophy (8).

Because the sole use of VBM resulted in inconsistencies, its combination with alternative morphometric techniques could lead to a clearer picture of gray matter integrity in OSA. Few studies used other analysis techniques and gray matter characteristics. Regional cortical thinning and reduced gray matter concentration were reported in middle-aged individuals with OSA (9, 10). Moreover, segmentation of predefined subcortical structures in individuals with OSA showed gray matter atrophy (hippocampi, mammillary bodies, caudate nuclei) (11–13) but also hypertrophy (hippocampi, putamen) (14, 15).

It is unclear whether OSA leads to altered structural gray matter integrity. This is especially true in the older population with OSA, for whom gray matter integrity has not been assessed thoroughly. The present study focuses on late middle-aged and older individuals, and investigates the association between OSA severity and gray matter characteristics estimated by different analysis techniques: volume and concentration measured with VBM; and cortical thickness and cortical/subcortical volume assessed with FreeSurfer automated segmentation. Instead of groups based on an arbitrary criterion to define OSA, we used a regression approach on a large sample with varying levels of OSA severity. The novelty of the study resides in the fact that it combines multiple analysis techniques and gray matter characteristics in association with multiple markers of OSA severity (hypoxemia, respiratory disturbances, and sleep fragmentation).

We hypothesized that all markers of OSA severity, but more particularly hypoxemia, would be linked to reduced gray matter in regions known to be sensitive to pathological processes observed in OSA (e.g., hippocampus and surrounding structures, prefrontal cortex) (1). We also hypothesized that an alternative method to VBM, namely FreeSurfer automated segmentation, could be more sensitive in revealing how OSA affects specific brain regions. Preliminary results have been previously reported in abstract form (16).

The online supplement describes the protocol in detail. The study included 71 subjects who were either healthy control subjects or newly diagnosed and untreated individuals with OSA. Thirty-seven of them (52%) participated in a previous study on cerebral perfusion in OSA (17). Ten subjects were recruited from a clinic for suspected OSA, whereas the remaining subjects were recruited through newspaper advertisements. Exclusion criteria included neurological, pulmonary, and major psychiatric diseases; sleep disorders other than OSA; OSA treatment including continuous positive airway pressure; uncontrolled diabetes and hypertension; morbid obesity; and medication affecting cerebral functioning. Ethics committees (#2012-697 and #12-13-008) approved the research protocol, and written consent was obtained from each subject.

Subjects were evaluated with an all-night in-laboratory polysomnographic recording and 3-T magnetic resonance imaging (MRI). Although the AHI is generally thought to represent OSA severity, its sole use has been challenged (18). Indeed, other variables related to oxygen saturation and sleep quality are also recognized as correlates of OSA severity. A principal component analysis was therefore used to extract independent markers of OSA severity, to reduce the number of statistical tests, and to prevent the multicollinearity problem of highly correlated variables in a regression. Respiratory and sleep variables that strongly correlated with the AHI (P < 0.001) were included in the principal component analysis. Although less correlated variables could be of interest, they may not fully reflect OSA pathophysiology and are not as well suited for a principal component analysis. Resulting rotated and uncorrelated components represented hypoxemia, respiratory disturbances, and sleep fragmentation (see Table 1).

Table 1. Markers of Obstructive Sleep Apnea Severity Obtained by a Principal Component Analysis of Respiratory and Sleep Variables

Respiratory and Sleep Variables Components
Hypoxemia Respiratory Disturbances Sleep Fragmentation
Minimal SpO2 , % −0.867 −0.330 −0.188
TST with SpO2  < 90%, min 0.815 0.408 0.175
Apnea‒hypopnea index, events/h 0.389 0.877 0.221
TST in apnea‒hypopnea, % 0.401 0.852 0.265
Microarousal index, events/h −0.002 0.404 0.816
Number of stage transitions to NREM1 and wakefulness 0.437 0.050 0.803
Accounted variance, % 32.0 32.3 24.9

Figure 1 depicts the neuroimaging analysis techniques used, that is, VBM and FreeSurfer automated segmentation. VBM was performed in accordance with published recommendations (8). T1-weighted MRI images were processed with the VBM8 toolbox (Structural Brain Mapping Group; http://www.neuro.uni-jena.de/) within SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). Default processing options were used to run the pipeline, including a spatial normalization that deformed every subject into a common space. The pipeline was run once with and once without modulation, which rescales images and transforms gray matter concentration into volume (19). A multiple regression design within SPM8 was performed between markers of OSA severity (hypoxemia, respiratory disturbances, and sleep fragmentation) and both gray matter volume and concentration, adjusted for age, sex, body mass index, and intracranial volume. The level of significance was set at P < 0.05 for clusters, corrected for multiple comparisons with topological false-discovery rate.

MRI images were also processed with FreeSurfer (http://surfer.nmr.mgh.harvard.edu/), which features the volumetric segmentation of subcortical structures (20) and the parcellation of the cortical surface (21) without a deforming spatial normalization. Cortical/subcortical volume and cortical thickness values from predefined brain regions were extracted for each subject. Hierarchical linear regressions for extracted FreeSurfer values were performed with age, sex, body mass index, and intracranial volume as covariates (step 1) and with markers of OSA severity (hypoxemia, respiratory disturbances, and sleep fragmentation; step 2). The level of significance was set at P < 0.01 for R 2 changes, that is, the increase in variance explained by adding OSA variables to covariates, and P < 0.01 for predicting markers of OSA severity.

Clinical Characteristics of the Sample

Seventy-eight subjects were evaluated by MRI. A neuroradiologist inspected the MRI images, which led to the exclusion of six subjects for major abnormalities such as silent infarcts or large arachnoid cysts. Another subject was excluded because of a processing problem, for a total of seven exclusions after the MRI.

The final sample was composed of 71 subjects ranging in age from 55 to 76 years (mean age, 65.3 ± 5.6 yr). Although the objective of the study was addressed with a regression design across the complete sample, subjects were divided into four groups based on their AHI and one-way analyses of variance were performed to better characterize the characteristics of our sample (see Table 2). Healthy control subjects (AHI, <5) represented 17% of the sample, 42% were included in the mild OSA group (AHI, between ≥5 and <15), 16% were included in the moderate OSA group (AHI, between ≥15 and <30), and 25% were individuals considered to have severe OSA (AHI, ≥30). The AHI varied from 0.2 to 96.6 events/hour, and 35% of the final sample had an OSA-related complaint and/or had suspected OSA before joining the study (e.g., snoring, daytime sleepiness, lack of energy, bed partner witnessing respiratory disturbances).

Table 2. Clinical and Polysomnographic Characteristics of Healthy Control Group and Mild, Moderate, and Severe Obstructive Sleep Apnea Groups

Variable Groups One-Way ANOVA
Control (A) (AHI, <5) Mild OSA (B) (AHI, ≥5 to <15) Moderate OSA (C) (AHI, ≥15 to <30) Severe OSA (D) (AHI, ≥30) F2 Post Hoc Tests
Number of subjects 12 30 11 18
Sex, female, n (%)* 2 (16.7) 10 (33.3) 1 (9.1) 3 (16.7) 3.7
Age, yr 62.3 (4.7) 65.8 (5.9) 65.9 (5.1) 66.1 (5.7) 1.4
Body mass index, kg/m2 26.5 (3.9) 26.5 (3.1) 27.9 (2.1) 28.7 (2.6) 2.6
Epworth Sleepiness Scale 6.5 (4.8) 7.2 (4.8) 9.7 (4.8) 8.2 (4.6) 0.6
Beck Depression Inventory 3.2 (3.7) 5.3 (4.9) 6.2 (5.2) 7.6 (5.9) 1.8
Beck Anxiety Inventory 4.3 (5.3) 3.1 (3.3) 3.2 (4.5) 4.0 (4.1) 0.2
Montreal Cognitive Assessment 27.4 (2.4) 27.5 (2.0) 27.5 (2.4) 26.9 (2.6) 0.3
Mini-Mental State Examination 28.1 (2.3) 29.0 (1.0) 28.2 (1.8) 29.2 (1.0) 2.6
Index of vascular burden 0.8 (0.8) 1.0 (1.1) 1.0 (0.9) 0.9 (0.8) 0.1
 Hypercholesterolemia, %* 25.0 36.7 36.4 44.4 1.2
 Hypertension, %* 41.7 40.0 54.6 39.0 0.8
Respiratory variables
 AHI, events/h 2.1 (1.5) 9.2 (2.5) 22.2 (4.8) 45.1 (19.5) 180.8 A < B < C < D
 TST in apnea–hypopnea, % 1.2 (1.1) 5.7 (2.0) 12.8 (1.9) 31.5 (15.5) 147.8 A < B < C < D
 Mean SpO2 , % 95.5 (0.6) 94.6 (1.2) 93.7 (0.7) 94.2 (1.2) 6.1 A > C, D
 Minimal SpO2 , % 90.5 (3.3) 88.5 (3.3) 83.6 (3.8) 81.5 (5.9) 16.3 A, B > C, D
 TST with SpO2  < 90%, min 0.1 (0.1) 2.0 (5.7) 5.5 (3.8) 17.6 (18.6) 26.2 A, B < C, D
Sleep variables
 TST, min 369.2 (60.7) 341.5 (64.5) 370.9 (43.9) 368.5 (46.0) 1.4
 Wake duration, min 100.8 (44.6) 101.3 (57.5) 80.2 (46.4) 91.6 (54.0) 0.6
 Sleep efficiency, % 78.5 (9.0) 77.2 (12.6) 82.6 (9.1) 80.6 (10.0) 0.8
 Microarousal index, events/h 12.0 (3.9) 14.3 (6.1) 14.3 (5.7) 25.2 (11.2) 8.8 A, B, C < D
 No. of stage transitions to NREM1 and wakefulness 56.9 (19.2) 55.1 (15.0) 66.8 (19.0) 97.8 (41.8) 9.6 A, B < D

Groups were statistically comparable for the Epworth Sleepiness Scale, the Beck Depression and Anxiety Inventories, the Montreal Cognitive Assessment, the Mini-Mental State Examination, and the Index of Vascular Burden (see Table 2). Markers of OSA severity extracted by the principal component analysis (see Table 1) did not correlate with any of these questionnaires and tests. In fact, a minority of subjects with mild-to-severe OSA had excessive daytime sleepiness (33% with Epworth Sleepiness ≥ 10), depressive symptoms (26% with Beck Depression Inventory II ≥ 10), anxiety symptoms (12% with Beck Anxiety Inventory ≥ 10), and cognitive deficits (16% with Montreal Cognitive Assessment < 26). In summary, this suggests that our participants were not highly symptomatic in terms of sleepiness, mood, and global cognition, and that this symptomatology was not related to OSA severity. Moreover, a minority of subjects with OSA was obese (25% with a body mass index ≥ 30 kg/m2) or had more than one cardiovascular risk factor and disease (31% with an Index of Vascular Burden > 1).

Gray Matter Hypertrophy and Thickening with OSA Severity

VBM revealed no significant association between OSA severity and clusters of gray matter volume or concentration at a false discovery rate–corrected threshold (P< 0.05).

Conversely, with FreeSurfer automated segmentation, significant regression models revealed increases, but no decrease, in cortical thickness and volume associated with markers of OSA severity (see Table 3, Figure 2 , and Figure E1 in the online supplement). The majority of significant models were of increased cortical thickness in relation to the level of hypoxemia. More severe hypoxemia was associated with increased thickness of the left rostral middle frontal gyrus, the right frontal pole, the right superior and inferior parietal lobules, and the left posterior cingulate cortex. Hypoxemia levels were also positively correlated with the volume of the left pars orbitalis portion of the inferior frontal gyrus. Moreover, higher levels of respiratory disturbances were associated with a hypertrophic right amygdala whereas an increased level of sleep fragmentation was correlated with a thicker pars triangularis region of the right inferior frontal gyrus.

Table 3. Significant Hierarchical Linear Regressions between Markers of Obstructive Sleep Apnea Severity and Regions of Increased Gray Matter Volume and Thickness Segmented Automatically with FreeSurfer

Brain Region Step 1: Nuisance Covariates Age Sex BMI ICV Step 2: OSA Severity Hypoxemia Respiratory Disturbances Sleep Fragmentation
Subcortical volume
 R amygdala
  R 2 31.9%* 47.9%*
ΔR 2 16.0%*
β −0.07 0.01 0.05 0.52* −0.06 0.39* 0.16
Cortical volume
 L pars orbitalis (inferior frontal)
  R 2 11.8% 30.0%*
ΔR 2 18.3%*
β −0.03 0.05 −0.08 0.30 0.44* −0.02 −0.12
Cortical thickness
 L rostral middle frontal gyrus
  R 2 8.9% 29.4%*
ΔR 2 20.5%*
β −0.24 −0.02 0.11 −0.23 0.47* 0.13 0.02
 R frontal pole
  R 2 0.0% 19.1%
ΔR 2 18.8%*
β 0.00 −0.00 0.03 −0.06 0.45* 0.11 0.03
 R pars triangularis (inferior frontal)
  R 2 6.5% 22.9%
ΔR 2 16.5%
β −0.16 0.11 0.18 −0.15 0.23 0.17 0.32*
 R superior parietal lobule
  R 2 7.7% 24.3%
ΔR 2 16.7%
β −0.11 0.03 0.22 0.04 0.40* 0.17 0.09
 R inferior parietal lobule
  R 2 3.8% 20.8%
ΔR 2 17.0%
β −0.17 0.00 0.09 −0.08 0.43* 0.13 −0.08
 L posterior cingulate cortex
  R 2 5.9% 23.7%
ΔR 2 17.8%*
β −0.08 −0.18 0.15 −0.03 0.36* 0.29 0.08

Complementary Results of Gray Matter Hypertrophy and Thickening with OSA Severity

Interestingly, similar positive associations were observed at a trend level with FreeSurfer (R 2 change between P < 0.05 and P > 0.01; predicting OSA components, P < 0.01; β values between 0.24 and 0.40) for contralateral cortical regions in relation to hypoxemia levels (thickness of the right rostral middle frontal gyrus, left inferior parietal lobule, and right posterior cingulate cortex) as well as for subcortical regions in association with more respiratory disturbances (volume of the left amygdala, hippocampus, and thalamus).

To assess whether gray matter structure is associated with markers of OSA severity even in milder forms of OSA, analyses were conducted among control subjects and subjects with mild-to-moderate OSA (AHI, <30). With FreeSurfer, increased gray matter was found in relation to hypoxemia in several frontoparietal regions and respiratory disturbances in the left thalamus and precuneus (see the online supplement).

This study investigated the association between markers of OSA severity and gray matter integrity in untreated individuals aged 55 years and older. We found that higher levels of hypoxemia during sleep were associated with increased volume and/or thickness of the prefrontal, parietal, and cingulate regions of the cortex. Moreover, a higher number of respiratory disturbances was associated with an enlarged amygdala whereas more fragmented sleep was correlated with a thicker frontal cortex. Our hypothesis was only partially confirmed because we predicted that atrophied gray matter would be associated with increased OSA severity. The novelty of this study lies not only in its results, but also in the use of specific markers of OSA severity in relation to multiple cerebral gray matter characteristics.

Potential Mechanisms Underlying Gray Matter Increases with OSA Severity

It would be surprising that gray matter increases underlie better neuron viability or neurogenesis. Indeed, neurogenesis in the adult brain is less probable outside the hippocampus, the subventricular zone, and the olfactory bulb (22). Gray matter hypertrophy and thickening may instead result from cerebral edema, a well-known effect of hypoxemia that can be observed after only 16 hours in protocols imitating altitude in humans (23). Consistently, a diffusion MRI study in individuals with newly diagnosed OSA suggested the presence of vasogenic edema in subcortical structures (24). In addition to edema, hypoxia causes changes in cellular size or quantity with the potential to enlarge gray matter. In fact, studies on rodents subjected to intermittent hypoxia during their sleep (1–10 d and 5 wk, respectively) showed increased brain water content, branching of surviving neurons, as well as astroglial hyperplasia and/or hypertrophy (i.e., reactive gliosis) (3, 25). Increased gray matter in relation to hypoxemia levels could also be representative of early neurodegeneration processes. Multiple animal models of hypoxic exposure (from a few hours to several days) consistently showed increased β-amyloid generation (1), a pathogenic mechanism of Alzheimer's disease. β-Amyloid deposition in the absence of abnormal tau levels has been reported to correlate with increased cortical thickness (26).

Overall, intermittent hypoxemia is probably a key mechanism leading to cerebral edema, cellular responses, and early neurodegeneration in gray matter. This is consistent with our findings because most regions with increased gray matter were associated with hypoxemia levels. Similarly, hypoxemia strongly correlated with gray matter increases even when subjects with severe OSA were removed from the analysis, confirming that milder forms of OSA are also associated with gray matter changes in our sample. At the clinical level, it suggests that intermittent hypoxemia may be particularly important to consider when making decisions for treatment, even in patients with an AHI score less than 30.

In addition to the relationship between hypoxemia and gray matter characteristics, respiratory disturbances and sleep fragmentation were also associated with gray matter hypertrophy or thickening in the present study. Sleep fragmentation and changes in breathing pattern due to obstructions were both shown to be independently associated with blood pressure fluctuations (27, 28), which could lead to cerebral edema (29). Furthermore, experimental obstructive apneas and sleep fragmentation may distinctly provoke cellular responses through various mechanisms, such as cerebral oxidative stress (2, 4). However, the specific effects of respiratory disturbances and sleep fragmentation are less understood than the effects of intermittent hypoxemia.

Increases versus Decreases of Gray Matter Structure in OSA

Although the existing literature mostly reports gray matter losses among individuals with OSA (7–13), gray matter hypertrophy has also been observed (14, 15, 30–32). The same pattern is shown with the effect of OSA treatment on gray matter. In one set of studies, treatment led to gray matter hypertrophy, suggesting a recovery from atrophic processes (33, 34), whereas others showed that OSA treatment reduced either regional gray matter or whole brain volume (31, 35), suggesting reversal of hypertrophic processes such as brain edema.

Increased gray matter may represent a presymptomatic stage of the OSA disease process during which its severity is characterized by reactive and adaptive brain mechanisms, such as cerebral edema, reactive gliosis, neuronal branching, and increased β-amyloid deposition. Later in the disease progression, gray matter atrophy could represent predominantly neuronal damage due to chronic OSA and lead to cognitive decline. Both adaptive and maladaptive effects on the brain have consistently been described for processes that follow cycles of airway obstructions and reoxygenation (36). Our sample had low levels of symptoms, namely sleepiness, mood, and cognitive deficits, indicating that most subjects were in a presymptomatic stage of OSA that may be characterized by more adaptive brain responses and, thus, increased gray matter. Obviously, these hypotheses must be confirmed.

OSA duration might affect the balance between adaptive and maladaptive mechanisms, but it is generally unknown. In hypoxic rodent and human protocols that observed mechanisms that could underlie increased gray matter, exposure to hypoxia was relatively short (from a few hours to several days) (1, 3, 23, 25). Gray matter hypertrophy and thickening could therefore be present in an earlier stage of the disease, although duration of hypoxic exposure in rodent and human protocols is difficult to translate to OSA in a clinical setting.

Age could also determine whether atrophy or hypertrophy is observed in reaction to OSA. In fact, OSA in older adults is possibly different in terms of mechanisms, comorbidities, consequences, and symptoms compared with younger patients. Age is associated with partially protective mechanisms against OSA, such as reduced production of oxidative stress after apneas (37) and decreased blood pressure and heart rate responses after arousals (38). Adaptive effects of hypoxia on the brain could lead to relative cerebrovascular protection and reduced mortality risk in older subjects (over age 50 yr) with OSA compared with their younger counterparts (39). Therefore, a different response to OSA could occur with age, and its severity may be correlated with increases in gray matter structure. Few studies have specifically evaluated gray matter in subjects over age 50 years. These had different designs and objectives and, thus, diverging results (40–42). Therefore, how OSA impacts the aging brain must be clarified.

Vulnerability of Specific Brain Regions to OSA

In the present study, markers of OSA severity were associated with increased thickness or volume in the lateral prefrontal cortex, the parietal lobules, and posterior cingulate cortex as well as the amygdala. Interestingly, previous studies on OSA showed both increased and decreased gray matter volume and/or thickness in the same or adjacent regions as those reported in the present study (9, 11, 13–15, 30–32, 43, 44). Therefore, these regions may be especially vulnerable to OSA and be preferentially affected by both swelling and atrophic processes. It is also important to highlight that we found trends for association between OSA markers of severity and increased gray matter in contralateral brain regions. It would be interesting to monitor this cohort to verify whether these trends will reach significance over time.

Hypoxemia and sleep fragmentation correlated with the structure of the lateral prefrontal cortex in our study. It has been suggested that the prefrontal cortex is vulnerable to both hypoxemia and sleep disruption in OSA (45). In addition, our results showed that hypoxemia was associated with core constituents of the default mode network, namely the parietal and posterior cingulate regions of the cortex. The metabolic activity levels of these highly connected regions fluctuate together (46), and their elevated oxygen demand could make them more vulnerable to hypoxemia (47). Finally, we found that amygdala volume was linked to respiratory disturbances, which is consistent with its altered activity during a respiratory challenge in subjects with OSA (48).

Usefulness of Complementary Gray Matter Analysis Techniques and Characteristics

Although the most widely used technique for gray matter analysis is VBM, we observed no changes when using this method, a result supported by previous studies on OSA (35, 49). VBM has limitations including misregistration and reduced accuracy of region location (19). This might be exacerbated by ventricular expansion caused by global atrophy in normal aging, in which processing errors could lead to false results in regions surrounding the ventricles. FreeSurfer automated segmentation may be more sensitive in detecting early changes in OSA than a voxel-based approach, because volume and thickness are computed by region without a prior spatial normalization. Instead, the brain is labeled and segmented in an automated manner similar to manual volumetry (20, 21), which probably represents more closely the real structure. However, FreeSurfer automated segmentation is time-consuming and depends on predefined atlases.

VBM and FreeSurfer segmentation show results on different scales. Whereas VBM investigates the brain voxel by voxel (1.5 mm3), the predefined regions extracted with FreeSurfer are much larger. This suggests that increases in gray matter with OSA severity are subtle and diffuse across a given brain structure, which could have been missed in some previous VBM studies. In addition, more regions of increased thickness than volume were observed with FreeSurfer, a result that may also have been missed with VBM. Overall, FreeSurfer automated segmentation and its measurement of cortical thickness seems to be more sensitive than VBM in detecting gray matter increases with OSA severity. However, our results must be replicated by further studies in the older population with OSA.

Strengths and Limitations

Our large sample size of 71 subjects with an AHI varying from 0.2–96.6 events/hour represents the entire spectrum of OSA severity, which allowed a regression approach. This eliminated the need for an arbitrary criterion to define the presence of the condition that is necessary for a between-group design, leading to inconsistencies between studies. A regression design also allowed us to investigate different markers of OSA severity. Moreover, the use of different analysis techniques and gray matter characteristics yielded a more complete evaluation of gray matter in OSA.

Nonetheless, the fact that most of our subjects were not severely hypoxic (see Table 2) and were mostly presymptomatic restricts the generalization of our results to other individuals with OSA. Although our strict exclusion criteria facilitate the interpretation of our findings by excluding many confounding conditions, they could limit the generalization of our results to individuals presenting with OSA and comorbidities.

Although we included sex as a nuisance covariate, women with OSA may present more maladaptive than adaptive cerebral processes. In fact, compared with men with comparable OSA severity, women have impaired white matter integrity (50). Because we investigated only 16 women (23% of our sample), this could explain the difference between our results and the study by Celle and colleagues (40), which showed brainstem atrophy among mostly women (64%) in a similar age group.

Conclusions

Our study revealed that markers of OSA severity, that is, hypoxemia, respiratory disturbances, and sleep fragmentation, are linked to increases in cortical thickness and gray matter volume that are more sensitively detected by a technique alternative to VBM, namely FreeSurfer automated segmentation. OSA severity, especially hypoxemia, could contribute to gray matter hypertrophy and thickening through local edema and reactive cellular responses. These structural changes in frontal, parietal, and cingulate regions of the cortex and in the amygdala may be possible in presymptomatic and/or older subjects with OSA, among whom more adaptive than maladaptive mechanisms may occur. Longitudinal investigations are needed to determine whether increased gray matter structure will later show atrophy and be associated with cognitive decline to deepen our understanding of the link between OSA and neurodegeneration in the aging population.

The authors thank Hélène Blais, Caroline d'Aragon, Caroline Arbour, Christophe Bedetti, Jean Paquet, Dominique Petit, Joëlle Robert, Sarah-Hélène Julien, Maria Tuineag, Maxime Fortin, Marc-André D. Gareau, Erlan Sanchez, Danielle Gilbert, Carollyn Hurst, and André Cyr for help with subject recruitment, data collection, and contribution to statistical analyses.

1. Daulatzai MA . Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J Neurosci Res 2015;93:17781794.
2. Almendros I , Farré R , Planas AM , Torres M , Bonsignore MR , Navajas D , Montserrat JM . Tissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia. Sleep 2011;34:11271133.
3. Aviles-Reyes RX , Angelo MF , Villarreal A , Rios H , Lazarowski A , Ramos AJ . Intermittent hypoxia during sleep induces reactive gliosis and limited neuronal death in rats: implications for sleep apnea. J Neurochem 2010;112:854869.
4. Nair D , Dayyat EA , Zhang SX , Wang Y , Gozal D . Intermittent hypoxia–induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea. PLoS One 2011;6:e19847.
5. Osorio RS , Gumb T , Pirraglia E , Varga AW , Lu SE , Lim J , Wohlleber ME , Ducca EL , Koushyk V , Glodzik L , et al.; Alzheimer's Disease Neuroimaging Initiative. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 2015;84:19641971.
6. Chang WP , Liu ME , Chang WC , Yang AC , Ku YC , Pai JT , Huang HL , Tsai SJ . Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan. PLoS One 2013;8:e78655.
7. Weng HH , Tsai YH , Chen CF , Lin YC , Yang CT , Tsai YH , Yang CY . Mapping gray matter reductions in obstructive sleep apnea: an activation likelihood estimation meta-analysis. Sleep 2014;37:167175.
8. Celle S , Delon-Martin C , Roche F , Barthélémy JC , Pépin JL , Dojat M . Desperately seeking grey matter volume changes in sleep apnea: a methodological review of magnetic resonance brain voxel-based morphometry studies. Sleep Med Rev 2016;25:112120.
9. Joo EY , Jeon S , Kim ST , Lee JM , Hong SB . Localized cortical thinning in patients with obstructive sleep apnea syndrome. Sleep 2013;36:11531162.
10. Joo EY , Tae WS , Lee MJ , Kang JW , Park HS , Lee JY , Suh M , Hong SB . Reduced brain gray matter concentration in patients with obstructive sleep apnea syndrome. Sleep 2010;33:235241.
11. Dusak A , Ursavas A , Hakyemez B , Gokalp G , Taskapilioglu O , Parlak M . Correlation between hippocampal volume and excessive daytime sleepiness in obstructive sleep apnea syndrome. Eur Rev Med Pharmacol Sci 2013;17:11981204.
12. Kumar R , Birrer BV , Macey PM , Woo MA , Gupta RK , Yan-Go FL , Harper RM . Reduced mammillary body volume in patients with obstructive sleep apnea. Neurosci Lett 2008;438:330334.
13. Torelli F , Moscufo N , Garreffa G , Placidi F , Romigi A , Zannino S , Bozzali M , Fasano F , Giulietti G , Djonlagic I , et al. Cognitive profile and brain morphological changes in obstructive sleep apnea. Neuroimage 2011;54:787793.
14. Kumar R , Farahvar S , Ogren JA , Macey PM , Thompson PM , Woo MA , Yan-Go FL , Harper RM . Brain putamen volume changes in newly-diagnosed patients with obstructive sleep apnea. Neuroimage Clin 2014;4:383391.
15. Rosenzweig I , Kempton MJ , Crum WR , Glasser M , Milosevic M , Beniczky S , Corfield DR , Williams SC , Morrell MJ . Hippocampal hypertrophy and sleep apnea: a role for the ischemic preconditioning? PLoS One 2013;8:e83173.
16. Baril AA , Gagnon K , Brayet P , Montplaisir J , de Beaumont L , Carrier J , Lafond C , L'Heureux F , Gagnon JF , Gosselin N . Increased gray matter volume and cortical thickness with markers of obstructive sleep apnea severity in middle-aged and older adults [abstract]. J Sleep Res 2016;25:259.
17. Baril AA , Gagnon K , Arbour C , Soucy JP , Montplaisir J , Gagnon JF , Gosselin N . Regional cerebral blood flow during wakeful rest in older subjects with mild to severe obstructive sleep apnea. Sleep 2015;38:14391449.
18. Asghari A , Mohammadi F . Is apnea–hypopnea index a proper measure for obstructive sleep apnea severity? Med J Islam Repub Iran 2013;27:161162.
19. Mechelli A , Price CJ , Friston KJ , Ashburner J . Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 2005;1:105113.
20. Fischl B , Salat DH , Busa E , Albert M , Dieterich M , Haselgrove C , van der Kouwe A , Killiany R , Kennedy D , Klaveness S , et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341355.
21. Fischl B , van der Kouwe A , Destrieux C , Halgren E , Ségonne F , Salat DH , Busa E , Seidman LJ , Goldstein J , Kennedy D , et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14:1122.
22. Riddle DR , Lichtenwalner RJ . Neurogenesis in the adult and aging brain. In: Riddle DR , editor. Brain aging: models, methods, and mechanisms. Boca Raton, FL: CRC Press; 2007.
23. Kallenberg K , Bailey DM , Christ S , Mohr A , Roukens R , Menold E , Steiner T , Bärtsch P , Knauth M . Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 2007;27:10641071.
24. Emin Akkoyunlu M , Kart L , Kilicarslan R , Bayram M , Aralasmak A , Sharifov R , Alkan A. Brain diffusion changes in obstructive sleep apnoea syndrome. Respiration 2013;86:414420.
25. Baronio D , Martinez D , Fiori CZ , Bambini-Junior V , Forgiarini LF , Pase da Rosa D , Kim LJ , Cerski MR . Altered aquaporins in the brains of mice submitted to intermittent hypoxia model of sleep apnea. Respir Physiol Neurobiol 2013;185:217221.
26. Fortea J , Vilaplana E , Alcolea D , Carmona-Iragui M , Sánchez-Saudinos MB , Sala I , Antón-Aguirre S , González S , Medrano S , Pegueroles J , et al.; Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Ann Neurol 2014;76:223230.
27. Chouchou F , Pichot V , Pepin JL , Tamisier R , Celle S , Maudoux D , Garcin A , Levy P , Barthelemy JC , Roche F ; PROOF Study Group. Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study. Eur Heart J 2013;34:21222131, 2131a.
28. Orban M , Bruce CJ , Pressman GS , Leinveber P , Romero-Corral A , Korinek J , Konecny T , Villarraga HR , Kara T , Caples SM , et al. Dynamic changes of left ventricular performance and left atrial volume induced by the Mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol 2008;102:15571561.
29. Skalidi SJ , Manios ED , Stamatelopoulos KS , Barlas G , Michas F , Toumanidis ST , Vemmos KN , Zakopoulos NA . Brain edema formation is associated with the time rate of blood pressure variation in acute stroke patients. Blood Press Monit 2013;18:203207.
30. Fatouleh RH , Hammam E , Lundblad LC , Macey PM , McKenzie DK , Henderson LA , Macefield VG . Functional and structural changes in the brain associated with the increase in muscle sympathetic nerve activity in obstructive sleep apnoea. Neuroimage Clin 2014;6:275283.
31. Lin WC , Huang CC , Chen HL , Chou KH , Chen PC , Tsai NW , Chen MH , Friedman M , Lin HC , Lu CH . Longitudinal brain structural alterations and systemic inflammation in obstructive sleep apnea before and after surgical treatment. J Transl Med 2016;14:139.
32. Lundblad LC , Fatouleh RH , Hammam E , McKenzie DK , Macefield VG , Henderson LA . Brainstem changes associated with increased muscle sympathetic drive in obstructive sleep apnoea. Neuroimage 2014;103:258266.
33. Rosenzweig I , Glasser M , Crum WR , Kempton MJ , Milosevic M , McMillan A , Leschziner GD , Kumari V , Goadsby P , Simonds AK , et al. Changes in neurocognitive architecture in patients with obstructive sleep apnea treated with continuous positive airway pressure. EBioMedicine 2016;7:221229.
34. Canessa N , Castronovo V , Cappa SF , Aloia MS , Marelli S , Falini A , Alemanno F , Ferini-Strambi L . Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med 2011;183:14191426.
35. O'Donoghue FJ , Briellmann RS , Rochford PD , Abbott DF , Pell GS , Chan CH , Tarquinio N , Jackson GD , Pierce RJ . Cerebral structural changes in severe obstructive sleep apnea. Am J Respir Crit Care Med 2005;171:11851190.
36. Rosenzweig I , Glasser M , Polsek D , Leschziner GD , Williams SC , Morrell MJ . Sleep apnoea and the brain: a complex relationship. Lancet Respir Med 2015;3:404414.
37. Dalmases M , Torres M , Márquez-Kisinousky L , Almendros I , Planas AM , Embid C , Martínez-Garcia MA , Navajas D , Farré R , Montserrat JM . Brain tissue hypoxia and oxidative stress induced by obstructive apneas is different in young and aged rats. Sleep 2014;37:12491256.
38. Goff EA , O'Driscoll DM , Simonds AK , Trinder J , Morrell MJ . The cardiovascular response to arousal from sleep decreases with age in healthy adults. Sleep 2008;31:10091017.
39. Lavie L , Lavie P . Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses 2006;66:10691073.
40. Celle S , Peyron R , Faillenot I , Pichot V , Alabdullah M , Gaspoz JM , Laurent B , Barthélémy JC , Roche F . Undiagnosed sleep-related breathing disorders are associated with focal brainstem atrophy in the elderly. Hum Brain Mapp 2009;30:20902097.
41. Dalmases M , Solé-Padullés C , Torres M , Embid C , Nuñez MD , Martínez-Garcia MA , Farré R , Bargalló N , Bartrés-Faz D , Montserrat JM . Effect of CPAP on cognition, brain function, and structure among elderly patients with OSA: a randomized pilot study. Chest 2015;148:12141223.
42. Sforza E , Celle S , Saint-Martin M , Barthélémy JC , Roche F . Hippocampus volume and subjective sleepiness in older people with sleep-disordered breathing: a preliminary report. J Sleep Res 2016;25:190193.
43. Macey PM , Henderson LA , Macey KE , Alger JR , Frysinger RC , Woo MA , Harper RK , Yan-Go FL , Harper RM . Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med 2002;166:13821387.
44. Zhang Q , Wang D , Qin W , Li Q , Chen B , Zhang Y , Yu C . Altered resting-state brain activity in obstructive sleep apnea. Sleep 2013;36:651659B.
45. Beebe DW , Gozal D . Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002;11:116.
46. Passow S , Specht K , Adamsen TC , Biermann M , Brekke N , Craven AR , Ersland L , Grüner R , Kleven-Madsen N , Kvernenes OH , et al. A close link between metabolic activity and functional connectivity in the resting human brain [abstract]. EJNMMI Phys 2015;2:A78.
47. Raichle ME , MacLeod AM , Snyder AZ , Powers WJ , Gusnard DA , Shulman GL . A default mode of brain function. Proc Natl Acad Sci USA 2001;98:676682.
48. Harper RM , Macey PM , Henderson LA , Woo MA , Macey KE , Frysinger RC , Alger JR , Nguyen KP , Yan-Go FL . fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects. J Appl Physiol (1985) 2003;94:15831595.
49. Innes CR , Kelly PT , Hlavac M , Melzer TR , Jones RD . Decreased regional cerebral perfusion in moderate–severe obstructive sleep apnoea during wakefulness. Sleep 2015;38:699706.
50. Macey PM , Kumar R , Yan-Go FL , Woo MA , Harper RM . Sex differences in white matter alterations accompanying obstructive sleep apnea. Sleep 2012;35:16031613.

Supported by the Canadian Institutes of Health Research (CIHR, MOP123294) and by the Fonds de Recherche du Québec–Santé (FRQ-S). The CIHR supported A.-A.B. with a doctoral scholarship and J.-F.G. with an Investigator Salary Award. The FRQ-S also supported P.B. with a doctoral scholarship in addition to N.G., L.D.B., and J.C. with a Salary Award. J.-F.G. holds a Canada Research Chair in Cognitive Decline in Pathological Aging, and J.M. holds a Canada Research Chair in Sleep Medicine.

Author Contributions: A.-A.B. contributed to the study's conception and design and to data acquisition, analysis, and interpretation; A.-A.B. also drafted the paper and revised it after the other authors' comments. K.G. and P.B. contributed to the study's design, to data acquisition and interpretation, and to critical revision of the work. L.D.B., J.M., C.L., J.C., and J.-F.G. contributed to the study's conception and to data interpretation, and revised the work critically. F.L'H. contributed to data acquisition and analysis, and revised the work critically. N.G. contributed to the study's conception and design and to data interpretation; N.G. also helped draft the paper and revised it critically. All authors approved the final version for publication and are accountable for all aspects of the work.

This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org

Originally Published in Press as DOI: 10.1164/rccm.201606-1271OC on January 6, 2017

Author disclosures are available with the text of this article at www.atsjournals.org.

orvissuppinfood.blogspot.com

Source: https://www.atsjournals.org/doi/10.1164/rccm.201606-1271OC

0 Response to "Grey Matter Does Not Continue to Thicken Throughout Adulthood"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel